COVAXIN Phase 3 Clinical Trials Data Submitted to DCGI by Bharat Biotech, Say Govt Sources
Bharat Biotech submitted Phase 3 clinical trials data of COVAXIN to Drugs Controller General of India (DCGI) over the weekend, Say Govt sources.
Bharat Biotech submitted Phase 3 clinical trials data of COVAXIN to Drugs Controller General of India (DCGI) over the weekend: Govt sources.
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)